Collective X Health Raises $3.2M in Pre-Seed Funding

Collective X Health, a San Francisco, CA-based women’s health and performance intelligence platform, has raised $3.2 million in a Pre-Seed funding round.

The round was co-led by Council Capital and Anthemis Female Innovators Lab Fund, with participation from SoGal Ventures, Emerson Collective, Muse Capital, and Segal Ventures.

The company will use the funding to expand its research, improve its intelligence platform, meet growing enterprise demand, and support new research in women’s health.

What is Collective X Health?

Collective X Health develops a women’s health intelligence platform that turns scientific research and female-specific data into structured, research-backed insights.

Read More:Mogul Raises $15.5M in Series A Funding Led by Draper Associates

Its platform provides an API that wearables, digital health companies, performance brands, and sports teams can use to deliver health, performance, and recovery insights based on female physiology.

The platform cites its research sources for each insight. Businesses can use it as their main women’s health database or to validate information in an existing database.

How Much Funding Has Collective X Health Raised?

Collective X Health has raised $3.2 million in its pre-seed funding round.

The source does not provide details of any previous funding rounds or the company's total funding to date.

Who Invested in Collective X Health’s Pre-Seed Round?

The round was co-led by:

• Council Capital
• Anthemis Female Innovators Lab Fund

Other participating investors include SoGal Ventures, Emerson Collective, Muse Capital, and Segal Ventures.

Why the Funding Matters

Collective X Health will use the funding to deepen its research across women's life stages and health conditions, expand its intelligence platform, and meet early enterprise demand.

The company also plans to support new research aimed at addressing gaps in women's health data.

Who founded Collective X Health?

Collective X Health was founded by Lindsey Abramo, Stacy Sims, and Angelica Marden. The company is based in San Francisco, California.

Its Research Lead Collective is headed by Dr. Stacy Sims and includes more than 20 medical doctors and PhDs who review and verify the company's research base.

“Women’s health isn’t a niche market. It’s half the population, yet less than 9% of NIH funding reflects that,” said Lindsey Abramo, Co-Founder and CEO. “Every company claiming to serve women should be able to show the research behind that claim.”

“Collective X’s edge isn’t a smarter model. It’s a smarter foundation underneath the model,” said Elizabeth Davis, Partner, Anthemis Female Innovators Lab Fund. “Instead of every wearable and health platform trying to solve the same research problem on its own, CX gives the entire women’s health ecosystem an evidence layer to build on.”

Market and Business Growth

Collective X Health's founding customers are licensing its women's health intelligence through an API to provide health, performance, and recovery insights.

The company has research and data partnerships with academic journals, Open Medicine Foundation, WildAI, and Eternal. It also has a pipeline of more than 50 prospective partners.

Its research grant programme includes a $200,000 commitment from human performance company Momentous to support sports science research and help address the gender data gap.

What Happens Next?

Collective X Health plans to expand its research coverage, strengthen its intelligence platform, and scale its enterprise business.

The company will also support further research in women's health to help businesses deliver more accurate, evidence-based insights for women.

Read More:Scuba Secures $34M in Total Funding Led by Accel